My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Tesla Is In Its AI Era: $3 Trillion Market Ca...
Microsoft, Palantir Lead A Software Rout Not...
Nasdaq Hits Record $5 Billion Revenue As Tech...
Nvidia Secures Approval For $105 Million Taiw...
Salesforce Hits Fresh 52-Week Low As Microsof...
Meta Stock Climbs After Q4 Reveals Blue Skies...
Microsoft Stock Plummets After Q2 Results: An...
Boeing Expands Global Footprint With Air Indi...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    STATE STREET SPDR S&P PHARMACEUTICALS ETF (AMEX: XPH)

    Overview
    current price
    $55.23
    $55.23
    change
    -0.60 | -1.07%
    -0.60 | -1.07%
    Yesterday's Close
    55.83
    open
    55.49
    volume
    0.04 M
    30d. avg volume.
    0.12 M
    1 day
    54.95 - 55.89
    52 weeks
    35.22 - 58.00
    p/e
    0.00
    beta
    0.5592
    market cap
    0.29 B
    dividend yield
    0.83%
    Industry
    -
    XPH by TradingView
    News and Commentary
    Here’s Why Investors Should Consider Biotech, Pharmaceutical Stocks The financial markets are not the most pleasant and calm place right now. It's facing risks in multiple areas such as geopolitics, inflation, and economic growth. There's also th...
    ETF Weekly: Industry Leaders Discuss 2020 Trends at Inside ETFs As exchange-traded fund industry leaders are meeting for the Inside ETFs, the world's largest ETF conference, this week, let's take a look at the latest trends that will be discu...
    ETF Weekly: Funds to Watch Post U.S.-China Trade Deal Stocks have had a volatile start to the week due to investors not knowing the full effect the trade agreement will have on the market and futures. The United States and China sig...
    StockTwits
    StockTwits
    Most Shared
    Dan Ives Sees 25% Tech Stock Breakout — Micron And Three Bargain Stocks Stand Out
    US Consumer Sentiment Hits 5-Month Highs As Inflation Worries Fall To 1-Year Low
    Nvidia Takes On Robotaxis With Chips, Software And Big Ambitions
    Most Popular
    Sam Altman To Host AI Town Hall — Asks Builders To Submit Questions As OpenAI Begins To Build 'New Generation Of Tools'
    Meta Pauses Global Launch Of Ray-Ban Smart Glasses After US Rush
    Nvidia Is Bank of America's Top Chip Pick: AI Demand, Pricing Power Drive Growth
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Coronavirus Impact
    Tesla
    Google
    Covid-19
    China
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?